|1.||Massuger, Leon F A G: 1 article (08/2007)|
|2.||Oei, Angèle L M: 1 article (08/2007)|
|3.||Oyen, Wim J G: 1 article (08/2007)|
|4.||Verheijen, René H: 1 article (06/2007)|
|5.||Massuger, Leon F: 1 article (06/2007)|
|6.||Seiden, Michael V: 1 article (06/2007)|
|7.||Lopes, Alberto: 1 article (06/2007)|
|8.||Epenetos, Agamemnon A: 1 article (06/2007)|
|9.||Oei, Angèle L: 1 article (06/2007)|
|10.||Soper, John T: 1 article (06/2007)|
|1.||Ovarian Neoplasms (Ovarian Cancer)
08/01/2007 - "We conducted a single-arm study to determine the biodistribution of intraperitoneally (i.p.) administered 90yttrium-labeled murine monoclonal antibody HMFG1 (90Y-muHMFG1) in patients with advanced stage ovarian cancer. "
06/15/2007 - "This study analyzes the site of disease recurrence in ovarian cancer patients to assess the influence of a single intraperitoneal (IP) administration of yttrium-90-labeled murine monoclonal antibody HMFG1 ((90)Y-muHMFG1) on the pattern of disease recurrence. "
11/01/1990 - "Radioimmunoscintigraphy with I-123 labeled monoclonal antibody HMFG1 has been used for imaging primary and metastatic ovarian neoplasms. "
05/01/1995 - "The development of stable chelating agents for metal isotopes (e.g., 90Y) such as CITC-DTPA, a benzyl-analog of DTPA, allowed us to evaluate the efficacy of 90Y-labeled HMFG1 MAb administered intraperitoneally in patients with ovarian cancer. "
07/01/1990 - "A phase 1-2 trial of 90Y-labelled monoclonal antibody, HMFG1 administered intraperitoneally to 30 patients with ovarian carcinoma is presented. "
09/01/2003 - "In the present study, the therapeutic efficacy of RIT with murine monoclonal antibody HMFG1 labeled with three different beta-radiation emitting radionuclides (90Yttrium, 186Rhenium, and 131Iodine) was assessed in athymic BALB/c mice with intraperitoneally growing NIH:OVCAR-3 ovarian carcinoma xenografts. "
|3.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/01/1990 - "They received escalating doses of intraperitoneally (IP) administered yttrium-90 (Y-90)-labeled monoclonal antibody, HMFG1, against a tumor cell-surface antigen. "
04/01/1988 - "Immunoscintigraphy using F(ab')2 fragments of tumor-associated monoclonal antibody HMFG1 was performed in 14 patients with primary and metastatic non-small cell carcinoma of lung cancer. "
10/01/2003 - "R-1549 (formerly known as pemtumomab), a murine monoclonal antibody (HMFG1) specific for the cancer antigen PEM and radiolabeled with yttrium-90, is under development by Antisoma and Roche as a potential treatment for ovarian and gastric cancer. "
|3.||Pentetic Acid (DTPA)
|5.||6- (4- isothiocyanatobenzyl)- diethylenetriamine pentaacetic acid
|7.||monoclonal antibody HMFG1 (pemtumomab)
|9.||Surface Antigens (Surface Antigen)
|1.||Heterologous Transplantation (Xenotransplantation)